Nivolumab +/- Ipilimumab in Patients With Advanced, Refractory Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Tumors (NECs)
Clinical trial NCT03591731 · COMPLETED
Trial details
- NCT number
- NCT03591731
- Sponsor
- Intergroupe Francophone de Cancerologie Thoracique
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-02
- Primary completion
- 2021-07-09
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.